- Home
- SNEX vs CRNX Comparison
SNEX vs CRNX Comparison
Compare SNEX & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SNEX | CRNX |
|---|---|---|
| Founded | 1924 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.9B | 4.1B |
| IPO Year | 1994 | 2018 |
Fundamental Metrics
Financial Performance| Metric | SNEX | CRNX |
|---|---|---|
| Price | $127.42 | $42.70 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 9 |
| Target Price | ★ $122.00 | $75.78 |
| AVG Volume (30 Days) | 418.1K | ★ 1.0M |
| Earning Date | 02-04-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 20.93 | N/A |
| EPS | ★ 6.76 | N/A |
| Revenue | ★ $141,825,700,000.00 | $1,535,000.00 |
| Revenue This Year | N/A | $499.13 |
| Revenue Next Year | $5.97 | $893.14 |
| P/E Ratio | $18.86 | ★ N/A |
| Revenue Growth | 32.55 | ★ 47.74 |
| 52 Week Low | $65.00 | $24.10 |
| 52 Week High | $130.35 | $57.99 |
Technical Indicators
Market Signals| Indicator | SNEX | CRNX |
|---|---|---|
| Relative Strength Index (RSI) | 66.22 | 36.05 |
| Support Level | $110.21 | $43.94 |
| Resistance Level | $130.35 | $48.58 |
| Average True Range (ATR) | 4.77 | 2.53 |
| MACD | 0.85 | -0.77 |
| Stochastic Oscillator | 70.45 | 5.33 |
Price Performance
Historical ComparisonAbout SNEX StoneX Group Inc.
StoneX Group Inc is a Global brokerage and financial services firm. Its service offerings are execution, OTC / Market-Making, advisory services, Global payment solutions, market intelligence, Physical Trading and clearing services. The firm operates in four segments: Commercial, Institutional, Self-Directed/Retail, and Payments. Its customers include governmental and nongovernmental organizations, commercial banks, brokers, institutional investors, and investment banks. The company operates in the United States, South America, Europe, the Middle East and Asia, and other countries, out of which the majority of revenue is generated from the Middle East and Asia Region.
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.